We provide you with 20 years of free, institutional-grade data for EVAX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EVAX. Explore the full financial landscape of EVAX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Evaxion Biotech A/S(NASDAQ:EVAX) 
Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a ...
Share this website to your friends
The information provided in this report about EVAX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.